MGX

METAGENOMI THERAPEUTICS INC

MGX·59102M104·US·Common Stock·Healthcare - Biotechnology

MGX (METAGENOMI THERAPEUTICS INC) is held by 29 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.3M), RENAISSANCE TECHNOLOGIES LLC ($883,456), TWO SIGMA INVESTMENTS, LP ($611,304). Net institutional sentiment: Mixed.

29
Holders
(3 Elite)
$5M
Total Value
33% (30)
Consensus
10 buying - 20 selling
13F: Insider & Congress: Updated regularly
MGX

Smart Money Verdict

View all
Loading verdict
Held by 29 funds
3 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jun 10, 2026 · Activists none · Congress none

InsiderWMWein MatthewSell $724.84Jun 5, 2026
InsiderIJIrish JianSell $5KJun 5, 2026
InsiderWPWapnick PamelaSell $4KJun 5, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.1M(+1.9%)$1.3M0.0%-18.89%
18
Decreased
742,400(-5.8%)$883,4560.0%-28.21%
0
Increased
513,701(+3.4%)$611,3040.0%-34.94%
25
Increased
379,508(+87.8%)$451,6140.0%-42.67%
38
Decreased
288,665(-19.4%)$343,6720.0%-66.37%
0
Increased
257,631(+11.9%)$306,5810.0%-60.72%
18
Increased
171,251(+0.6%)$203,7890.0%-19.10%
16
Decreased
160,000(-58.1%)$190,4000.0%-19.21%
0
Decreased
119,850(-0.5%)$142,6220.0%-60.08%
0
Decreased
114,025(-33.0%)$135,6900.0%-29.57%
0
Increased
109,130(+38.8%)$129,8650.0%-32.46%
29
Decreased
68,938(-8.3%)$82,0360.0%-53.78%
0
Increased
55,707(+37.3%)$66,2910.0%-23.80%
28
Decreased
38,396(-74.7%)$45,6910.0%-22.21%
0
Increased
17,851(+5.0%)$21,2430.0%-22.80%
13
New
16,850$20,0520.0%+2.52%
29
Decreased
15,793(-1.9%)$18,7940.0%-42.75%
0
Unchanged
13,392$15,9360.0%-19.21%
0
Unchanged
12,797$15,2280.0%-23.75%
0
Decreased
5,302(-80.8%)$6,3090.0%-60.06%
0

Showing 1-20 of 36

1 / 2
MGXMGXMETAGENOMI THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used